Successful fatherhood of males with tyrosine kinase inhibitor-resistant chronic myeloid leukemia taking olverembatinib. Yu L, Jiang Q. Ann Hematol 2025 Nov 14. doi: 10.1007/s00277-025-06722.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yu L, Jiang Q. Successful fatherhood of males with tyrosine kinase inhibitor-resistant chronic myeloid leukemia taking olverembatinib. Ann Hematol 2025 Nov 14. doi: 10.1007/s00277-025-06722.
PMID: 41236637